← All stories
Markets
GSK (LSE:GSK) leans harder on dealmaking — what is the drugmaker actually assembling?
Highlights GSK has agreed to acquire a Canadian clinical-stage biotech focused on pulmonary hypertension A gene-silencing licensing agreement with a China-based partner extends its kidney disease reach The shares eased alongside the wider p…
Covered by 1 outlet
All coverage · 1 article